ArticleGenetics2026
Reflections on the Human Genome Diversity Project: a conversation with Marcus W. Feldman, Henry T. Greely, and Mary-Claire King.
Article in Genetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
The Human Genome Diversity Project (HGDP) began in 1991 as an initiative to study genetic variation from human populations worldwide. In 2002, the HGDP reported the HGDP-CEPH Human Genome Diversity Cell Line Panel, a global panel of 1064 cell lines that is maintained at the Centre d'Etude du Polymorphisme Humain (CEPH) and that has served as a major resource fundamental to the last 25 years of progress in human population genetics. HGDP-CEPH data have been central to research on topics such as human genetic diversity, human population structure, human migrations, the development of population-genetic statistics and software, and the potential value of inclusion of diverse sets of human populations in biomedical research. In this article, two researchers who participated in early analyses of genotypes from the HGDP-CEPH panel in the early 2000s speak with three researchers who played key roles in developing the Human Genome Diversity Project from its origin in 1991. The conversation reflects on the successes and challenges of the effort to launch the HGDP and on its scientific contributions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.